Autism Journal Club

EU-AIMS-2: What do we think?

In June this year, the " largest research grant ever given for neurodevelopmental conditions" was awarded to the "AIMS-2-trials" consortium to further their work to "increase our understanding of autism and help develop new therapies to improve health outcomes and quality of life for autistic people." In this Journal Club session we will explore what this consortium does, what we think of it, and some of the reactions to this announcement so far (see and follow the twitter trail)